FDA Drug Application (020745) for ZANTAC 75 by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number020745
Product Number001
FormTABLET, EFFERVESCENT;ORAL
DosageEQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZANTAC 75
Active IngredientRANITIDINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient RANITIDINE HYDROCHLORIDE7


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM